The uniquely co-located site will utilise the unrivalled healthcare infrastructure of:
Birmingham Health Partners , the Institute of Translational Medicine (ITM) and the BioHub Birmingham, among many other centres of research and practice excellence all within close proximity to BHIC.
It will build on BHP’s integrated clinical-academic vision to deliver research that matters, making BHIC an exciting proposition as part of the evolution of life sciences in not only Birmingham but the wider region and UK.
The campus is being delivered through a long-term collaboration between the University of Birmingham, as landowner, and experienced investor-developers Bruntwood SciTech. It will become the only science park in the region dedicated to health and life sciences, sitting at the heart of a critical cluster of health excellence, led by BHP, creating opportunities for transformative collaborations between businesses, the University and NHS partners.
Businesses located at the site will also benefit from access to Bruntwood SciTech’s specialist business support and partner network, enabling them to grow at pace and scale with access to finance, talent and new markets.
This will be a pioneering and globally significant location that brings together outstanding researchers, clinicians, policy makers and industry to rapidly translate scientific and clinical insights into patient benefit and economic growth. It will reinforce Birmingham’s global role, supporting innovative new partnerships and leveraging strong existing collaborations. Working with and for our large, diverse regional patient and public communities, it will be unparalleled in its ability to co-create dynamic solutions to some of the biggest challenges in life sciences and healthcare. It will benefit from outstanding clinical data integration and analytics, real world evidence and patient engagement.
To find out more about the extensive and innovative life sciences research happening at Birmingham, visit the life sciences website.